HOW WE WORK

We bring structure to complex questions.

Our approach is collaborative, evidence-led and focused on decision impact. Built to bring clarity to programmes operating at the edge of science, execution and capital.

WHEN ORGANISATIONS TYPICALLY ENGAGE WITH CELLVANTA

Critical decisions often emerge long before problems become visible.

Preparing for a financing or partnership discussion

01

Ensuring technical narratives align with development reality and execution risk.

Evaluating platform or manufacturing readiness

02

Assessing whether technologies, processes and supporting infrastructure are ready for the next stage of development.

Planning major process or analytical changes

03

Understanding the comparability, regulatory and operational implications of change.

Assessing development risk

04

Identifying assumptions, dependencies and execution challenges before they become expensive to address.

Evaluating investment opportunities

05

Providing independent scientific and technical perspectives on readiness, manufacturability and development strategy.

Navigating uncertainty

06

Supporting teams facing decisions where the path forward is technically complex but time-sensitive.

ENGAGEMENT PRINCIPLES

Flexible engagement. Meaningful impact.

We work alongside you at pivotal moments. Bringing clarity, de-risking decisions and unlocking pathways forward.

Strategic and technical advisory

CMC and analytical development guidance

Technical due diligence and TRL/MRL benchmarking

WHO WE PARTNER WITH

Founders. Innovators. Investors. Institutions.

United by a mission to improve lives.

Biotech & Startups

Founders building advanced therapy programmes.

Venture Capital & Investors

Funds, family offices and corporate venture teams.

Academic & Research Institutions

Translational science teams shaping clinical futures.

Industry & Strategic Partners

CDMOs, biotech companies and strategic collaborators.

Understand

01

We listen first. We align on objectives, constraints and the decision context (what success looks like), who needs to act on what we deliver and by when.

Assess

02

We evaluate data, assumptions, risks and technical realities by applying TRL/MRL frameworks alongside AI-enabled tooling where useful. Where evidence is incomplete, we say so.

Synthesise

03

We translate complexity into clear insights and strategic options. No padded reports. The output is what helps you decide and formatted for the audience that needs to act on it.

Deliver

04

We support confident decisions and stronger execution through clear recommendations, working sessions, network introductions and follow-through where it matters.

Structured thinking. Independent perspective. Decisions you can act on.